Economy, Stocks

“Dow closes down 600 points, Nasdaq enters correction after weak jobs report…” [Aug 3 2024]

“Stocks fell sharply on Friday as a much weaker-than-anticipated jobs report for July ignited worries that the economy could be falling into a recession. The broad market index dropped 1.84% to end at 5,346.56. The Nasdaq Composite lost 2.43% to close at 16,776.16, bringing… Continue Reading…

Stocks

“Nvidia Stock Just Dropped More Than 18% In 15 Days. Should Investors Be Worried?” [Jul 31, 2024]

“…So what gives? Should investors be worried? In short, probably not. Stocks naturally retreat after big gains. It’s to be expected; in fact, it’s healthy. Yes, 18% is a lot, many stocks move less over the course of a year,… Continue Reading…

Stocks

“AMD jumps 5% as global chip stocks rally after earnings and geopolitics lift sector”

“Shares of global semiconductor firms rallied on Wednesday as they were boosted by some positive earnings in the sector and a report of potentially less severe U.S. export restrictions on China. AMD was among the big winners with shares up… Continue Reading…

Stocks

“Worried About A Looming 40% Crash? It’s Here Already For 12 Stocks”

“Twelve stocks in the S&P 500, including Walgreens Boots Alliance (WBA), Dexcom (DXCM) and Super Micro Computer (SMCI), have already crashed 40% or more from their 52-week highs, says an Investor’s Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge. A 40% decline is… Continue Reading…

Business, Stocks

“Procter & Gamble earnings beat estimates, but quarterly sales disappoint as China demand slides”

“…Shares of the company fell 5% in morning trading. Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG: P&G reported fiscal fourth-quarter net income attributable to the company of… Continue Reading…

Stocks

“Goldman Sachs Predicts up to 165% Surge for These 2 ‘Strong Buy’ Stocks”

“…RegenXBio (RGNX) The first Goldman pick we’ll look at is RegenXBio, a gene therapy company specializing in single-dose treatments for severe diseases with few or no existing therapies….  Choi rates RGNX a Buy along with a $38 price target. This… Continue Reading…

Stocks

“Thoma Bravo Raises $2.7 Billion in Nasdaq Stake Sale”

“…The private equity firm sold 41.6 million Nasdaq shares for $65.30 each, according to a statement by the exchange operator Monday. A Thoma Bravo affiliate was offering the stock for between $64.80 and $65.80 each, Bloomberg News reported Friday. The… Continue Reading…

Business, Stocks

“McDonald’s earnings, revenue miss estimates as consumer pullback worsens” [Jul 29 2024]

“Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG: The fast-food giant reported second-quarter net income of $2.02 billion, or $2.80 per share, down from $2.31 billion, or $3.15… Continue Reading…

Stocks

“Dexcom shares plummet almost 40% after company misses on revenue, lowers guidance” [Jul 25 2024]

“Shares of Dexcom tumbled almost 40% in extended trading Thursday after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. Here’s how the company did: Dexcom’s revenue increased 15% from $871.3 million a year earlier, according to a… Continue Reading…

Economy, Predictions, Opinions, & Comments, Stocks

Now They’re Scared: “The Fed warns of social media ‘echo chambers’ that pump up meme stocks.”

“…“To date, the broad financial stability implications of changes in retail equity investor characteristics and behaviors have been limited,” the Fed said. The central bank specifically assessed what happened to shares of AMC Entertainment and GameStop in January, noting that activity and… Continue Reading…